-
Reagents
- Flow Cytometry Reagents
-
Western Blotting and Molecular Reagents
- Immunoassay Reagents
-
Single-Cell Multiomics Reagents
- BD OMICS-One™ WTA Next Assay
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD OMICS-One™ Protein Panels
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD OMICS-Guard™ CRYO Preservation Buffer
- BD OMICS-Guard™ Sample Preservation Buffer
- BD Rhapsody™ Accessory Kits
- Functional Assays
-
Microscopy and Imaging Reagents
-
Cell Preparation and Separation Reagents
-
Dehydrated Culture Media
-
BD Biosciences Training Program
- Flow Cytometry Basic Training
-
Product-Based Training
- BD Accuri™ C6 Plus Cell Analyzer
- BD FACSAria™ Cell Sorter Cell Sorter
- BD FACSCanto™ Cell Analyzer
- BD FACSDiscover™ A8 Cell Analyzer
- BD FACSDiscover™ S8 Cell Sorter
- BD FACSDuet™ Sample Preparation System
- BD FACSLyric™ Cell Analyzer
- BD FACSMelody™ Cell Sorter
- BD FACSymphony™ Cell Analyzer
- BD LSRFortessa™ Cell Analyzer
- Advanced Training
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Combining CRISPR and single-cell RNA-seq
Genome-wide association studies have uncovered thousands of immune disease-associated variants, yet most lie in non-coding regions, making it difficult to identify their target genes and mechanisms of action.
In this webinar, Dewi Moonen and Daniel Schraivogel of the European Molecular Biology Laboratory will discuss an experimental framework to link disease-associated variants to cis-regulatory elements and their downstream gene effects in primary human CD4+ T cells at scale.
Using CRISPR interference, coupled with targeted single-cell RNA sequencing with the BD Rhapsody™ HT Xpress System, the EMBL team systematically perturbed more than one thousand regulatory elements overlapping immune disease risk variants and directly measured their impact on candidate target genes and regulatory networks. By integrating causal perturbation data with chromatin, genetic, and regulatory network information, they uncovered functional regulatory interactions in a disease-relevant immune cell type.
Webinar attendees will learn how perturbation-based approaches can resolve variant-to-gene relationships, how regulatory elements can be functionally characterized at scale in primary cells, and how these data advance the interpretation of immune disease genetics.
Our speakers will also share best practices for performing large-scale CRISPR screens with single-cell RNA-sequencing and the BD Rhapsody™ System in a challenging primary cell type.
Speakers
![]() | Dewi Moonen, PhD European Molecular Biology Laboratory (EMBL) Genome Biology Unit, Heidelberg, Germany
|
![]() | Daniel Schraivogel, PhD European Molecular Biology Laboratory (EMBL) Genome Biology Unit, Heidelberg, Germany
Daniel Schraivogel is a visiting scientist in the laboratory of Prof. Dr. Lars Steinmetz at the European Molecular Biology Laboratory (EMBL). He pioneers novel functional genomics methods that integrate CRISPR/Cas9 genetic screening and single-cell multimodal readouts. He uses these technologies to map the function of genes, regulatory elements, and disease-associated variants and to identify disease mechanisms and drug targets. Prior to joining EMBL, Dr. Schraivogel completed his PhD in the laboratory of Prof. Dr. Gunter Meister at the Max-Planck-Institute (MPI) of Biochemistry in Munich and Regensburg University, studying the function of short non-coding RNAs and their associated proteins in health and disease. |
Access the On-Demand Webinar
*Required fields
For Research Use Only. Not for use in diagnostic or therapeutic procedures.

